Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ohkura Pharmaceutical is a Japanese pharmaceutical company specializing in the development, manufacturing, and distribution of ethical and over-the-counter (OTC) drugs. Founded in 1950 and headquartered in Kyoto, the company has established a niche in the production of external preparations, such as ointments, creams, and liquid medications, alongside oral solid dosages. In 2013, Ohkura was acquired by Nichi-Iko Pharmaceutical, a major player in the Japanese generic drug market, and now operates as a key manufacturing subsidiary within the Nichi-Iko Group. The company maintains a GMP-compliant facility that supports the production of high-quality generic medicines across therapeutic areas including dermatology, gastroenterology, and internal medicine. Ohkura is recognized for its long-standing history in the Japanese healthcare sector and its commitment to providing affordable, reliable therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OHKURA Pharmaceutical.